Weight may affect how breast cancer drugs work, study suggests
NCT ID NCT02095184
First seen Apr 17, 2026 · Last updated May 01, 2026 · Updated 3 times
Summary
This study aimed to find out if standard doses of aromatase inhibitors (hormone-blocking pills) work differently in overweight or obese postmenopausal women with early breast cancer compared to normal-weight women. About 42 women were planned to take anastrozole or letrozole before surgery to see how their tumors responded. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.